Celldex Therapeutics buy UBS Group AG
Start price
19:45
/
50%
€25.25
Target price
10.06.27
€38.97
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 10.06.27. The prediction end date can be changed by UBS_Group_AG at any time.Performance without dividends (%)
| Name | 1w |
|---|---|
| Celldex Therapeutics | - |
| iShares Core DAX® | -2.486% |
| iShares Nasdaq 100 | -4.401% |
| iShares Nikkei 225® | -4.295% |
| iShares S&P 500 | -2.199% |
Comments by UBS_Group_AG for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) had its price target raised by UBS Group AG from $38.00 to $45.00. They now have a "buy" rating on the stock.
Ratings data for CLDX provided by MarketBeat